Candel Therapeutics's total assets for Q3 2025 were $93.60M, a decrease of -11.67% from the previous quarter. CADL total liabilities were $13.47M for the fiscal quarter, a -14.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.